John Patrick Oroho Interview with Global Business Reports US Biopharmaceuticals 2020

May 29, 2020

What is your assessment of how the regulatory landscape has evolved over the last few years?

One of the legal areas strongly impacting companies and how they market their products is the push for price transparency. There are currently 14 US states with cost disclosure laws. In four of them, companies have to justify the price of their new products. For example, they are required to share what percentage of the price is attributable to research and development, licensing fees, sales forces and marketing. In some states you have to declare and rationalize price increases. Companies are considering how price increases might trigger…

To read the full interview, click here.

37 Ex-US Jurisdictions Served

4 Offices

370 Companies Served

Questions? Request more information or call 973-538-1690

Contact Us